Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
2002
Defining the role of post-mastectomy radiotherapy: the new evidence.
1996
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Contemporary Breast Radiotherapy and Cardiac Toxicity
2015
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
1992
Breast cancer
2016 Standout
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.
1995
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
1996
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries.
1998
Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression ☆ ☆This study was supported by the National Natural Science Foundation of China (No. 39870753) and Changhai Hospital ‘123’ Project.
2001
Repression of interleukin‐6 gene expression by 17β‐estradiol:
1997
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Cardiac Risks of Breast-cancer Radiotherapy: A Contemporary View
2006
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
2002
Chemoprevention strategies for the control of cancer
1993
Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
2005
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
1993
Systematic review of bisphosphonates for hypercalcaemia of malignancy
2004
Long-Term Cardiovascular Mortality After Radiotherapy for Breast Cancer
2011
Postmastectomy radiotherapy in the management of operable breast cancer
1994
Does tamoxifen cause cancer in humans?
1998
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
1994
Measuring inconsistency in meta-analyses
2003 Standout
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
2010 Standout
Uterine fibroids
2001 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
1989
Male breast cancer
2006 Standout
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
1992
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The process of metastasisation for breast cancer
2003
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
2013
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
2005 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.
1998
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
2003
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Cardiac Exposures in Breast Cancer Radiotherapy: 1950s–1990s
2007
Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975-1999
2002
Microenvironmental regulation of metastasis
2008 Standout
Breast cancer adjuvant therapy
1990
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
1996
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
2006
Production and Actions of Estrogens
2002 Standout
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
2010
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Endometrial cancer
1997
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation
2003
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection
2001
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Adjuvant Therapy for Breast Cancer: Practice Patterns of Community Physicians
2002
New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive Agent
1991
Clinical decision-making in early breast cancer.
1993
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma
1998
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
2006
Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
1990
Process Development for a Large Scale Stereoselective Synthesis of (Z)-(1-Bromobut-1-ene-1,2-diyl)dibenzene, a Key Intermediate of a Selective Estrogen Receptor Modulator
2010
Tamoxifen Versus Control After Adjuvant, Risk-Adapted Chemotherapy in Postmenopausal, Receptor-Negative Patients With Breast Cancer: A Randomized Trial (GABG-IV D-93)—The German Adjuvant Breast Cancer Group
2005
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
1996
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Efficacy of Screening Mammography
1995
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 Standout
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma
2000
Nonnuclear Actions of Estrogen
2002
Evolving concepts in the systemic adjuvant treatment of breast cancer.
1992
Endometrial Carcinoma
1996
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
A systematic review of the role of bisphosphonates in metastatic disease
2004
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
2005 Standout
Cardiovascular Complications of Cancer Therapy
2004
Works of Ulla Glas being referenced
The Stockholm trial on adjuvant tamoxifen in early breast cancer
1987
Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer
1990
Randomized Trial of Adjuvant Tamoxifen in Node Negative Postmenopausal Breast Cancer
1992
ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
1989
Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen Therapy
1991
Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality.
1991
Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
1989
The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.
1989
Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy
1997
Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.
1990
Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: A prospective study
1996
Randomized mammographic screening for breast cancer in Stockholm
1986
Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases—A prospective randomised placebo-controlled multicentre study
1992
Response to tamoxifen and fluoxymesterone in a group of breast cancer patients with disease recurrence after cessation of adjuvant tamoxifen.
1987
Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy
1997
Effect of Adjuvant Therapy in Primary Breast Cancer in Relation to the Estrogen Receptor Level
1984